Investigation of best concentration of desflurane

Investigation of best concentration of desflurane - Investigation of best concentration of desflurane

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010015

Enrollment

120

Registered

2013-02-13

Start date

2013-02-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who undergo general anesthesia by desflurane

Interventions

Desflurane 3.5% During general anesthesia Desflurane 4.5% During general anesthesia Desflurane 5.5% During general anesthesia Sevoflurane 1.3% During general anesthesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA-PS(American Society of Anesthesiologists - Physical Status) 1~2

Exclusion criteria

Exclusion criteria: (a) Patients with IHD (b) Patient with COPD (c) Renal or/and hepatic dysfunction (d) Obesity (BMI > 35) (e) Drug or/and alcohol abuse (f) Anemia (Ht < 25%) (g) Past or/and family history of malignant hyperthermia (h) Patient who underwent general anesthesia within 7 days

Design outcomes

Primary

Measure	Time frame
The elapsed time to eye opening, extubation and recovery of orientaion after finishing general anesthesia by desflurane	—

Secondary

Measure	Time frame
BIS, blood pressure, heart rate and total amount of remifentanil and desflurane used	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026